Category: Life Sciences
Global Life Sciences
-
Cholesterol Testing
... CAGR of 4.4% over the analysis period 2024-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$11.6 Billion by the end of the ... Read More
-
Laboratory Glassware and Plasticware
... 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Glass Pipettes and Pipette Tips, one of the segments analyzed in the report, is expected to record a 1.5% CAGR and reach US$636.1 ... Read More
-
Gastrointestinal (GI) Endoscopy Devices
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$25.5 ... Read More
-
ENT and Bronchoscopy Devices
... 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Endoscopes, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$7.8 Billion by the end ... Read More
-
Hormone Replacement Therapy (HRT)
... 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Estrogen Hormone Replacement Therapy, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$24.2 Billion ... Read More
-
Anti-Counterfeit Packaging
... CAGR of 9.2% over the analysis period 2024-2030. Mass Encoding Technology, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$109.6 Billion by the end of the ... Read More
-
Heart Healthy Ingredients
... at a CAGR of 4.2% over the analysis period 2024-2030. Omega-3 Ingredient, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$12.4 Billion by the end of ... Read More
-
Acute Heart Failure (AHF) Therapeutics
... Billion by 2030, growing at a CAGR of 21.0% over the analysis period 2024-2030. Cardiac Glycosides, one of the segments analyzed in the report, is expected to record a 21.5% CAGR and reach US$762.4 Million ... Read More
-
Dental Implants
... CAGR of 6.1% over the analysis period 2024-2030. Titanium Material, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$10.2 Billion by the end of the analysis ... Read More
-
mHealth (Mobile Health) Services
... 2030, growing at a CAGR of 27.9% over the analysis period 2024-2030. Monitoring Services, one of the segments analyzed in the report, is expected to record a 27.0% CAGR and reach US$139.8 Billion by the ... Read More
-
Biomarkers
... 13.7% over the analysis period 2024-2030. Safety Biomarkers, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$89.8 Billion by the end of the analysis period. Growth ... Read More
-
Prenatal Diagnostics
... CAGR of 12.8% over the analysis period 2024-2030. Non-Invasive Test, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$10.6 Billion by the end of the analysis ... Read More
-
Circulating Tumor Cell (CTC) Diagnostics
... Billion by 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Detection & Enrichment Technology, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach ... Read More
-
Biosimulation Technology
... CAGR of 15.6% over the analysis period 2024-2030. Biosimulation Software, one of the segments analyzed in the report, is expected to record a 14.8% CAGR and reach US$5.7 Billion by the end of the analysis ... Read More
-
Biopreservation
... 8.0% over the analysis period 2024-2030. Biopreservation Media, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$5.1 Billion by the end of the analysis period. Growth ... Read More
-
Dental Preventive Supplies
... at a CAGR of 4.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$156.3 Million While China is Forecast to Grow at 6.4% CAGR The Dental Preventive Supplies market in the U.S. ... Read More
-
Acute Coronary Syndrome
... at a CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 16.2% CAGR The Acute Coronary Syndrome market in the U.S. ... Read More
-
Sports Nutrition Supplements
... at a CAGR of 5.8% over the analysis period 2024-2030. Amino Acids / Derivatives, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.6 Billion by the ... Read More
-
Arthroscopy Instruments
... CAGR of 7.0% over the analysis period 2024-2030. Arthroscopy Implants, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$5.8 Billion by the end of the analysis ... Read More
-
Medical X-Ray
... CAGR of 5.1% over the analysis period 2024-2030. Digital Technology, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$13.5 Billion by the end of the analysis ... Read More
-
Cables and Leads for Medical Equipment
... reach US$6.0 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. ECG Application, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach ... Read More
-
Cardiac Defibrillators
... CAGR of 7.9% over the analysis period 2024-2030. Implantable / Internal Cardiac Defibrillator, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$12.3 Billion by the end ... Read More
-
Imaging Agents
... CAGR of 4.5% over the analysis period 2024-2030. Diagnostic Radiopharmaceuticals, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$7.2 Billion by the end of the analysis ... Read More
-
Mammography Equipment
... CAGR of 6.8% over the analysis period 2024-2030. 2-D Digital Mammography Systems, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$2.1 Billion by the end of ... Read More
-
Pulse Oximeters
... CAGR of 3.7% over the analysis period 2024-2030. Handheld Pulse Oximeters, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$1.5 Billion by the end of the ... Read More
Research Assistance
